Proglumide attenuates experimental colitis in rats

Experimental and Toxicologic Pathology

Volumn 56, Issue 4-5, 2005, Pages 327-332

  Al Moutaery, Ahmed ^a   Tariq, Mohammad ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Cholecystokinin; Colitis; Myeloperoxidase; Rat

Indexed keywords

ACETIC ACID; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; MYELOPEROXIDASE; PROGLUMIDE; SODIUM CHLORIDE;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; HEAD POSITION; HISTOPATHOLOGY; INTERSTITIUM; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; ORGAN WEIGHT; PROTECTION; RAT; SCORING SYSTEM;

EID: 14644443548     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2004.04.007     Document Type: Article

References (39)

1. L.G. Axelsson, E. Landstrom, and A.C. Bylund-Fellenius Experimental colitis induced by dextran sulphate sodium in mice beneficial effects of sulphasalazine and olsalazine Aliment Pharmacol Ther 12 1998 925 934
2. R.D. Beauchamp, C.M. Townsend Jr., P. Singh, E.G. Glass, and J.C. Thompson Proglumide, a gastric receptor antagonist, inhibits growth of colon cancer and enhances survival in mice Ann Surg 202 1985 303 309
3. C. Beglinger Effect of cholecystokinin on gastric motility in humans Ann NY Acad Sci 713 1994 219 225
4. C.J. Bell, D.G. Gall, and J.L. Wallace Disruption of colonic electrolyte transport in experimental colitis Am J Physiol 268 1995 G622 G630
5. I.I. Blandino, M. Otaka, M. Jin, K. Komatsu, M. Odashima, N. Konishi, T. Sato, S. Kato, and S. Watanabe FR 167653, a potent suppressant of interleukin-1 and tumor necrosis factor-alpha production production, ameliorates colonic lesions in experimentally induced acute colitis Gastroenterol Hepatol 16 2001 1105 1111
6. P. Bobek, V. Nosalova, and S. Cerna Effect of pleuran (beta-glucon from Pleurotus ostreatus) in diet or drinking fluid on colitis in rats Nahrung 45 2001 360 363
7. S. Choudhary, A. Keshavarzian, S. Yong, M. Wade, S. Bocckino, B.J. Day, and A. Banan Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats Dig Dis Sci 46 2001 2222 2230
8. J.D. Cohen, H.W. Kao, S.T. Tan, J. Lechago, and W.J. Snape Jr. Effect of acute experimental colitis on rabbit colonic smooth muscle Am J Physiol 251 1986 G538
9. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
10. 2 inhibitors on acetic acid induced acute colitis in the rat Br J Surg 80 1993 1199 1204
11. J.C. Fantone, and P.A. Ward Polymorphonuclear leukocyte mediated cell and tissue injury oxygen metabolites and their relations to human disease Hum Pathol 16 1985 973 978
12. S.E. Goldblum, K.M. Wu, and M. Jay Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits J Appl Physiol 59 1985 1978 1985
13. L. Grossi, K. McHugh, and S.M. Collins On the specificity of altered muscle function in experimental colitis in rats Gastroenterology 104 1993 1049
14. K. Hayashi, S. Kishimoto, and M. Kannbe Endogenous CCK inhibits colonic contractions in unrestrained conscious rats Regul Pept 72 1997 131 137
15. K. Jacobsen, K. McHugh, and S.M. Collins Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat Gastroenterology 109 1995 718
16. R.T. Jensen Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders Pharmacol Toxicol 91 2002 333 350
17. M. Karaus, and C. Niederau Effect of CCK-receptor activity in dogs Neurogastroenterol Motil 7 1995 63 71
18. F. Karmeli, P. Cohen, and D. Rachmilewitz Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats Eur J Gastroenterol Hepatol 12 2000 223 231
19. I. Khan, S.M. Hussein, and M.A. Oriowo Studies on the expression and function of beta-3-adrenoceptors in the colon of rats with acetic acid-induced colitis Pharmacology 64 2002 98 105
20. J.S. Lane, K.E. Todd, M.P. Lewis, B. Gloor, S.W. Ashley, H.A. Reber, D.W. McFadden, and C.F. Chandler Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion Surgery 122 1997 288 294
21. F. Loher, K. Schmall, P. Freytag, N. Landauer, R. Hallwachs, C. Bauer, B. Siegmund, F. Rieder, H.A. Lehr, M. Dauer, J.F. Kapp, S. Endres, and A. Eigler The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice J Pharmacol Exp Ther 305 2003 549 556
22. B.M. Meyer, B.A. Werth, C. Beglinger, P. Hildebrand, J.B. Jansen, D. Zach, L.C. Rovati, and G.A. Stalder Role of cholecystokinin in regulations of gastrointestinal motor functions Lancet 2 1989 12 15
23. L.R. Miller, A.H. Maurer, B.J. Chase, R. Vitti, R.S. Fisher, and B. Krevsky Abnormal patterns of regional colonic transit in ulcerative colitis Gastroenterology 96 1989 344A
24. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
25. B.S. Myers, D.T. Dempsey, H.P. Parkman, J.S. Martin, and J.P. Ryan Acetic acid induced colitis decreases colonic circular smooth muscle contractility in rats Gastroenterology 110 1996 A1405
26. B.S. Myers, D.T. Dempsey, S. Yasar, J.S. Martin, H.P. Parkman, and J.P. Ryan Acute experimental distal colitis alters colonic transit in rats J Surg Res 69 1997 107 112
27. C. Niederau, S. Faber, and M. Karaus Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome Gastroenterology 102 1992 1889 1898
28. M. Noa, R. Mas, D. Carbajal, and S. Valdes Effect of D-002 on acetic acid-induced colitis in rats at single and repeated doses Pharmacol Res 41 2000 391 395
29. V. Nosalova, S. Cerna, and V. Bauer Effect of N-acetylcysteine on colitis induced by acetic acid in rats Gen Pharmacol 35 2000 77 81
30. C.E. Pendley, L.R. Fitzpatrick, R.W. Ewing, B.F. Molino, and G.E. Marini The gastrin/cholecystokinin-β receptor antagonist L-365,260 reduces based acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat J Pharm Exp Ther 265 1993 1348 1354
31. S.S.C. Rao, C.D. Holdsworth, and N.W. Read Symptoms and stool patterns in patients with ulcerative colitis Gut 29 1988 342
32. S.S.C. Rao, and N.W. Read Gastrointestinal motility in patients with ulcerative colitis Scand J Gastroenterol 25 suppl 172 1990 22
33. S.N. Reddy, G. Bazzocchi, S. Chan, K. Akashi, J. Villanueva-Meyer, G. Yanni, L. Mena, and W.J. Snape Jr. Colonic motility and transit in health and ulcerative colitis Gastroenterology 101 1991 1289
34. C. Scarpignato, and I. Pelosini Management of irritable bowel syndrome novel approaches to the pharmacology of gut motility Can J Gastroenterol 13 suppl A 1999 50A 65A
35. W.J. Snape Jr., and H.W. Kao Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis Dig Dis Sci 88 1988 65S
36. K. Takeuchi, T. Hirata, H. Yamomoto, T. Kunikata, M. Ishikawa, and Y. Ishihara Effects of S-0509, a novel CCK/gastrin receptor antagonists, on acid secretion and experimental duodenal ulcers in rats Aliment Pharmacol Ther 13 1999 87 96
37. M. Tariq, N.S. Parmar, and A.M. Ageel Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats J Pharm Exp Ther 241 1987 602 607
38. T.D. Wardle, L. Hall, and L.A. Turnberg Inter-relationship between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion Gut 34 1993 503
39. G.H. Wendel, A.O. Maria, F. Mohamed, S. Domingues, L. Scardapane, O.S. Giordano, E. Guerreiro, and J.A. Guzman Effect of dehydroleucodine in experimental colitis in rats and mice Pharmacol Res 40 1999 339 344